Prescient Therapeutics Limited (AU:PTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Prescient Therapeutics Limited has announced the cessation of 415,000 options due to their expiry on June 1, 2024, without being exercised or converted. This notification is provided as a formal disclosure to the market and represents a new announcement for the investors and stakeholders of the company.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.